Page results
-
A new trial led by UCLH and UCL is looking at whether music therapy can help patients recover from severe brain injury.
-
The Maternal Medicine team provides care for women with pre-existing medical disorders or pregnancy-related medical conditions. We work in a multidisciplinary team of doctors and midwives in order to provide the best standard of care for women and their babies.
-
The service includes diagnosis, quantifying the degree of hearing loss, and rehabilitation of hearing impairment to limit participation restriction.
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
This page provides information about anaesthesia for children having proton beam therapy.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
-
UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.
-
This page provides information about the thermoregulatory sweat test (TST).
-
Concerned about the impact of climate change on people with neurological conditions, Professor Sanjay Sisodiya has established established a consortium of neurological specialists and will be undertaking research.
-
This page has been written for patients having proton beam therapy (PBT) at University College Hospital (UCH).
File results
-
FOI/2022/0062 - Vehicle fleet information and governance
-
FOI/2022/0064 - Neonatal visiting policy/ visitation rights
-
FOI/2022/0068 - Staff and covid vaccinations
-
FOI/2022/0070 - Viscosupplementation use and spend
-
FOI/2022/0071 - Sodium Hyaluronate eye drops
-
FOI/2022/0076 - Private patient third party involvement
-
FOI/2022/0080 - Bariatric equipment
-
FOI/2022/0083 - Estates and inrastructure failures
-
FOI/2022/0084 - CA9030 - UCLH-2609 VAT Support and Advice Services contract
-
FOI/2022/0091 - Pancreatic cancer